Back to Top

Annemieke DeMaggio's blog

ESMO 2020 Preview, part 2: new and/or notable

As expected, the majority of ESMO orals will be IO related. As for small molecules, oral presentations include the usual line up of targets, but also some things new or noteworthy.

ESMO 2020 Preview, part 1: Further slicing and dicing of the EGFR mutation pie

Next generation TKIs are developed to target a broader spectrum of EGFR mutations. But can they overcome the challenges presented by exon 20 insertion mutations?


Subscribe to RSS - Annemieke DeMaggio's blog